Importantly, these visceral fat reductions occurred without significant changes in overall body weight
These choices are often based on personal experience rather than clinical evidence, making provider guidance important
Today is the Worst GLP1s+ Will Ever Be GLP1s+ More effective (5% to 22% weight loss and on their way to 25%+) More expansive disease management (diabetes, obesity, CVD, CKD, OSA, and studied for more) Less frequent (2x per day to 1x week and on their way to 1x/month to 1x/year?) Additional effective options in orals are on their way Insurance Coverage Medicare adding coverage for CVD (hopefully more diseases on the way as labels expand) Medicaid added 5 states in just 2023 Federal government added all employees and family members in 2023 Commercial employer coverage increased by 35% in 2023, with more employers considering it The Treat and Reduce Obesity Act (TROA) has been introduced in Congress to encourage Medicare coverage Costs Zepbound, a more effective drug, launched ~20-30% cheaper than Wegovy, with a savings card that put it at just over 1/3rd of the price at the time
Its crucial to consult with your healthcare provider before donating to ensure its safe for you
Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice (in Eng)
%25201.png)
